Close Menu

You may find more results for this query on our sister sites: GenomeWeb and 360Dx.

Home › About Us › Our Staff › Turna Ray

Turna Ray

Managing Editor, Precision Oncology News
Phone Number
+1-212-651-5626
Email
[email protected]
Turna Ray at Genomeweb / 360dx Turna Ray at Genomeweb / 360dx

Turna Ray has been covering the personalized medicine and molecular diagnostics industries for GenomeWeb since 2006. She closely tracks the evolving regulatory, reimbursement, and business environment for precision medicine products. 

Articles Authored by Turna Ray

Sep 24, 2020

Growing Data on Vitrakvi Demonstrate Enduring Activity Across Variety of NTRK-Positive Tumor Types

Premium

Data presented at ESMO showed that in 175 adults and children with more than 20 kinds of tumors the drug on average can stave off progression for more than three years.

Sep 21, 2020

Roche's Ipatasertib, Anti-Androgen Therapy Improves Outcomes in Prostate Cancer With PTEN Loss

Premium

A secondary analysis suggested that using NGS to identify patients with PTEN loss may be better than IHC in identifying best responders to treatment.

Sep 20, 2020

Conflicting ESMO Data Raise Questions About Role of CDK4/6 Inhibitors in Adjuvant Breast Cancer

Premium

Adding Verzenio to hormone therapy reduced the risk of relapse by 25 percent, while the PALLAS study, testing another CDK4/6 inhibitor, failed.

Sep 20, 2020

Pfizer's Lobrena Yields Impressive Responses in ALK-Positive NSCLC With Brain Metastases

Premium

The data may result in another option for patients in the crowded first-line ALK-positive lung cancer market, though progression-free survival data are not yet mature.

 

Sep 20, 2020

Vectibix, Bavencio Show Activity as 'Rechallenge' Therapy Strategy in Metastatic Colorectal Cancer

Premium

Although the benefit seen in the CAVE study needs Phase III confirmation, the analysis showed that plasma ctDNA testing may help identify best responders.

Sep 14, 2020

COVID-19 Experience Spurs Cancer Research Community to Embrace Telemedicine-Enabled Trials

Premium

The pandemic has underscored the importance of "bringing the trial to the patient," a concept that is likely to persist, particularly in precision oncology.

Sep 09, 2020

Genetic Testing Challenges in Oncology: Unnecessary Testing Identifies BRCA2 VUS in 16-Year-Old Girl

A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.

Aug 25, 2020

Acepodia's NK Cell Therapy Enters Human Studies in HER2 Expressing Solid Tumors

Premium

The company is hoping that ACE1702 will validate its antibody cell conjugation technology and show that its proprietary NK cells are more effective than current cell-based therapies.

Aug 12, 2020

Basket Trial Data Supports Further Study of Lynparza, Imfinzi Regimen in BRCA-Mutated Breast Cancer

Premium

Patients on the combo regimen had similar outcomes to those on monotherapy, but researchers said that the benefit seen in certain groups should be explored in randomized trials.

Aug 06, 2020

Genetic Testing Challenges in Oncology: Assuming All Labs Are Equal Gives False Reassurance of Risk

A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.